rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Insulet Corporation

PODD · Nasdaq

Health CareMedical DevicesNot moving yet

PODD stood above a rising 150-day average in 5 of the last 52 weekly readings, and has been out of that trend for the last 47 weeks. It is 11.7% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 47
Industry in uptrend
27% -7 in 4 wk
Insider buys, 12 months
$5.5M
Insider sales, 12 months
$662K
Officials’ trades on record
40
Institutions holding
677 (-53)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 5 of 52 weeks.

20 Apr – 19 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$4.0M$0$2.8MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

40 disclosed lines: House 11, Senate 12, executive 17; 9 people.

WhoDidAmountTraded
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31sold$1k–$15k18 Sep 2026filed 12 Oct 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k28 Aug 2026filed 8 Oct 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k24 Aug 2026filed 8 Oct 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k18 Aug 2026filed 10 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k10 Aug 2026filed 8 Oct 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$50k–$100k24 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k23 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k3 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$50k–$100k22 May 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k18 May 2026filed 1 Jul 2026
Tina Smith Senate: U.S. Senate eFDSenatorsoldspouse$100k–$250k7 May 2026filed 10 May 2026
Tina Smith Senate: U.S. Senate eFDSenatorsold part ofspouse$100k–$250k29 Apr 2026filed 10 May 2026

Insiders

Buy orders, 12 months6
Sale orders, 12 months2
Buyers · sellers4 · 2
WhoDidSharesTraded
Ashley McEvoyPresident and CEObought1,100at $147.4721 Aug 2026filed 24 Aug 2026
Elizabeth H. WeathermanDirectorbought3,450at $144.203 Jun 2026filed 3 Jun 2026
Luciana BorioDirectorsold418at $143.273 Jun 2026filed 4 Jun 2026
Timothy C. StonesiferDirectorbought2,790at $143.513 Jun 2026filed 4 Jun 2026
Michael R. MinogueDirectorbought2,030at $246.2325 Feb 2026filed 26 Feb 2026
Ashley McEvoyPresident and CEObought4,300at $239.3520 Feb 2026filed 23 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders677-53 on the quarter
New · exited91 · 144
Reported value$10.6B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20266,690,192$1.0B+314,249+4.9%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 20264,525,333$689.0M-53,941−1.2%
STATE STREET CORPadded · filed 7 Aug 20263,197,555$486.8M+155,101+5.1%
VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 20263,075,932$468.3M-374,055−10.8%
AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 20262,455,135$373.8M+856,411+53.6%
BAILLIE GIFFORD & COadded · filed 6 Aug 20262,042,313$310.9M+12,821+0.6%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 20262,003,861$304.0M-21,837−1.1%
TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 20261,903,734$289.8M+1,141,385+149.7%
Invesco Ltd.added · filed 14 Aug 20261,694,651$258.0M+598,114+54.5%
MORGAN STANLEYadded · filed 13 Aug 20261,479,050$225.2M+333,119+29.1%
31 Mar 2023 – 30 Jun 2026
468616763Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Flavia Pease Company insiderEVP & CFO · last 1 Oct 20260 · 0
Jonathan Jay Mazelsky Company insiderDirector · last 30 Sep 20260 · 0
Robert Luther Huffines Company insiderDirector · last 30 Sep 20260 · 0
Gilbert Ray Cisneros, Jr. HouseCA31 · last 18 Sep 20263 · 2
Donald J. Trump Executive branchWhite House Office · last 28 Aug 20268 · 9
Ashley McEvoy Company insiderPresident and CEO · last 21 Aug 20262 · 0
Lisa Blair Davis Company insiderSVP, Chief HR Officer · last 1 Aug 20260 · 0
Elizabeth H. Weatherman Company insiderDirector · last 3 Jun 20261 · 0
Luciana Borio Company insiderDirector · last 3 Jun 20260 · 6
Timothy C. Stonesifer Company insiderDirector · last 3 Jun 20262 · 0
Jessica Hopfield Company insiderDirector · last 20 May 20262 · 2
Michael R. Minogue Company insiderDirector · last 20 May 20262 · 0

Same industry

RCEL Avita MedicalLeading+100%
HAE HaemoneticsLeading+48%
ATRC AtriCureLeading+47%
HTFL HeartflowLeading+47%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202571.6%
Operating profit marginFY 2025 · to 31 Dec 202517.5%
Free cash flow marginFY 2025 · to 31 Dec 202513.9%
Return on capital employedFY 2025 · to 31 Dec 202518.9%
Cash conversionFY 2025 · to 31 Dec 2025230%
Debt to equityFY 2025 · to 31 Dec 20250.01×
Research spendFY 2025 · to 31 Dec 202511.1%
Share count trendFY 2025 · to 11 Feb 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$716.1M
Free cash flowFY 2025 · to 31 Dec 2025$377.7M

Analyst forecasts

No analyst forecasts yet.